April Chen
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 9
- Pharmacology 11
- Antibiotics Pharmacokinetics and Efficacy 10
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Alita A. Miller (6 shared papers)Adam B. Shapiro (4 shared papers)Nicole Carter (3 shared papers)Rubén Tommasi (5 shared papers)John P. O’Donnell (5 shared papers)Ning Gao (1 shared paper)Haris Jahić (1 shared paper)Sarah M. McLeod (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)Xenobiotica (2 papers)Drug Metabolism and Disposition (2 papers)ACS Infectious Diseases (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
April Chen
23 papers receiving 798 citations
Peers
Comparison fields: 5 of 89
- Molecular Medicine 251
- Applied Microbiology and Biotechnology 48
- Hepatology 162
- Pharmacology 170
- Pharmacology 59
Countries citing papers authored by April Chen
This map shows the geographic impact of April Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April Chen more than expected).
Fields of papers citing papers by April Chen
This network shows the impact of papers produced by April Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April Chen. The network helps show where April Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside April Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 133 | |
| 2 | 2021 | 115 | |
| 3 | 2008 | 87 | |
| 4 | 2015 | 73 | |
| 5 | 2017 | 56 | |
| 6 | 2020 | 55 | |
| 7 | 2008 | 53 | |
| 8 | 2009 | 50 | |
| 9 | 2011 | 49 | |
| 10 | 2009 | 37 | |
| 11 | 2015 | 25 | |
| 12 | 2023 | 24 | |
| 13 | 2017 | 21 | |
| 14 | 2020 | 19 | |
| 15 | 2020 | 17 | |
| 16 | 2024 | 11 | |
| 17 | 2023 | 9 | |
| 18 | 2012 | 8 | |
| 19 | 2024 | 5 | |
| 20 | 2015 | 4 |
About April Chen
April Chen is a scholar working on Molecular Medicine, Pharmacology, Hepatology, Pharmacology and Oncology, having authored 23 papers that have together received 855 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (9 papers), Pneumonia and Respiratory Infections (4 papers), Liver physiology and pathology (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Molecular Medicine (251 citations), Applied Microbiology and Biotechnology (48 citations), Hepatology (162 citations), Pharmacology (170 citations) and Pharmacology (59 citations). April Chen has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Alita A. Miller, Adam B. Shapiro, Nicole Carter, Rubén Tommasi, John P. O’Donnell, Ning Gao, Haris Jahić, Sarah M. McLeod, Liyue Huang and Min-Hwa Jasmine Lin. Their work appears in journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy, Xenobiotica, Drug Metabolism and Disposition and ACS Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.